Home
  1. Priv. Doz. Dr. Fahmy Aboulenein-Djamshidian
  2. Dr. Schiva Aboulenein-Djamshidian
  3. Dr. Said Albinni
  4. Dr. Nazem Atassi
  5. Dr. Georg Gonda
  6. Dr. Michael Rösch
  7. Bilder
  8. Für Ärzte
  9. Anfahrtsplan
  10. Kontakt
Zur Person
Behandlungsspektrum
Publikationen
Datenschutz

           Internationale Publikationen (Stand Jänner 2019)

  1. Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.
    Month-of-birth-effect in multiple sclerosis in Austria.
    Mult Scler. 2018;  [ahead of Print]
    zum Artikel

  2. Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P.
    Secondary dementia due to Lyme neuroborreliosis.
    Wien Klin Wochenschr. 2018; 15-16: 468-478.
    zum Artikel

  3. Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    J Neuroinflammation 2016 Jul 1; 13: 176. zum Artikel

  4. Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W. CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable? PLoS One 2015; 10: e0142272.
    zum Artikel
  weitere Publikationen >>
  1. Schanda K, Waters P, Holzer H, Aboulenein-Djamshidian F, Leite MI, Palace J, Vukusic S, Marignier R, Berger T, Reindl M. Antibodies to aquaporin-1 are not present in neuromyelitis optica.
    Neurol Neuroimmunol Neuroinflamm 2015; 2: e160.
    zum Artikel

  2. Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M. NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
    Neurol Neuroimmunol Neuroinflamm 2015; 2: e141.

    zum Artikel


  3. Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, Senel M, Tumani H, Hegen H. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Mult Scler. 2015 Jul 21. zum Abstrakt

  4. Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W.
    Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
    J Neuropathol Exp Neurol 2015; 74: 194-197.
    zum Artikel